Cardinal Health, Inc. (NYSE:CAH) Shares Bought by Price T Rowe Associates Inc. MD

Price T Rowe Associates Inc. MD boosted its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 3.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,601,322 shares of the company's stock after buying an additional 55,781 shares during the period. Price T Rowe Associates Inc. MD owned 0.66% of Cardinal Health worth $189,390,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of CAH. Mirae Asset Global Investments Co. Ltd. raised its position in Cardinal Health by 35.2% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company's stock valued at $3,871,000 after purchasing an additional 8,471 shares during the period. CHURCHILL MANAGEMENT Corp increased its stake in Cardinal Health by 1.5% during the 4th quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company's stock worth $28,435,000 after buying an additional 3,576 shares during the period. Consolidated Planning Corp grew its stake in shares of Cardinal Health by 40.0% in the fourth quarter. Consolidated Planning Corp now owns 8,926 shares of the company's stock worth $1,056,000 after acquiring an additional 2,552 shares in the last quarter. Flputnam Investment Management Co. increased its position in shares of Cardinal Health by 1.8% during the fourth quarter. Flputnam Investment Management Co. now owns 180,586 shares of the company's stock worth $21,358,000 after acquiring an additional 3,148 shares during the period. Finally, Patton Albertson Miller Group LLC acquired a new stake in shares of Cardinal Health in the fourth quarter valued at $258,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Price Performance

NYSE:CAH traded up $3.71 on Friday, reaching $149.24. The stock had a trading volume of 1,433,382 shares, compared to its average volume of 2,194,183. The company has a market cap of $36.05 billion, a price-to-earnings ratio of 27.82, a P/E/G ratio of 1.49 and a beta of 0.61. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $149.50. The firm's fifty day moving average is $131.95 and its two-hundred day moving average is $124.73.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.15 by $0.20. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The business had revenue of $54.88 billion for the quarter, compared to analysts' expectations of $55.33 billion. During the same period last year, the company earned $2.08 earnings per share. The company's quarterly revenue was up .0% on a year-over-year basis. As a group, research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st were paid a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.36%. The ex-dividend date of this dividend was Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is 37.69%.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Evercore ISI upgraded Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price target on the stock in a report on Tuesday, January 7th. Robert W. Baird upped their price target on shares of Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a research report on Friday. Bank of America increased their target price on Cardinal Health from $150.00 to $155.00 and gave the stock a "buy" rating in a research note on Friday, April 11th. Argus set a $148.00 price target on Cardinal Health in a research note on Tuesday, February 4th. Finally, Morgan Stanley increased their price objective on Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a research report on Friday, January 31st. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $144.71.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.